In our cohort, the most prevalent genetic abnormalities identified were ELAC2 mutations and very long-chain acyl-CoA dehydrogenase deficiency (VLCADD). Here, ELAC2 is linked to very long chain acyl-CoA dehydrogenase deficiency.